Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome/LabCorp’s MGMT Test

Premium
Laboratory Corporation of America this week commercially launched its MGMT methylation testing service to gauge patients’ responsiveness to cancer therapies. 
 
For the test, LabCorp licensed OncoMethylome's MSP and MGMT DNA methylation marker technology.
 
OncoMethylome Sciences will receive royalty and milestone payments from LabCorp on the sales of the MGMT methylation testing service. Financial terms of the deal were not announced.
 
While its deal with LabCorp is for the North American market, OncoMethylome noted that efforts are underway to extend commercial availability of its technology to the European markets.

Filed under

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.